Company Filing History:
Years Active: 2020-2021
Title: Innovations by Shu-Hsien Chang
Introduction
Shu-Hsien Chang is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in developing innovative dosage formulations for treating various medical conditions. With a total of two patents to his name, his work reflects a commitment to advancing healthcare solutions.
Latest Patents
Shu-Hsien Chang's latest patents include an oral pH independent dosage formulation for treating neurodegenerative disorders. This formulation is designed to contain both sustained-release and immediate-release drugs, specifically memantine and donepezil. It is characterized by a pH-independent dissolution profile of memantine across a pH range from about 1.0 to about 7.0. Another significant patent involves methods for treating hyperglycemia, which encompasses conditions such as type I and II diabetes mellitus. This invention utilizes (R)-(+)-verapamil or a pharmaceutically acceptable salt thereof, combined with an α-glycosidase inhibitor, to address disorders related to hyperglycemia.
Career Highlights
Shu-Hsien Chang is associated with Center Laboratories, Inc., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in developing effective treatments that cater to the needs of patients suffering from chronic conditions.
Collaborations
Some of his notable coworkers include Meng-Ju Lee and Chih-Chiang Yang, who contribute to the collaborative efforts in research and development at Center Laboratories, Inc.
Conclusion
Shu-Hsien Chang's contributions to pharmaceutical innovations demonstrate his dedication to improving healthcare outcomes. His patents reflect a deep understanding of complex medical conditions and a commitment to developing effective treatments.